Pressure BioSciences, Inc. (PBIO)
| Market Cap | 21.48K |
| Revenue (ttm) | 1.50M -25.3% |
| Net Income | -33.25M |
| EPS | -0.89 |
| Shares Out | 42.97M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 700 |
| Open | 0.0002 |
| Previous Close | 0.0005 |
| Day's Range | 0.0002 - 0.0005 |
| 52-Week Range | 0.0001 - 0.2000 |
| Beta | 5.91 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |
About Pressure BioSciences
Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company’s products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formulations; BaroFold Technology platform, that is used to improve the quality and lower the production costs of protein biotherapeutics; and Pressure Cycli... [Read more]
Financial Performance
In 2023, Pressure BioSciences's revenue was $1.98 million, an increase of 14.36% compared to the previous year's $1.73 million. Losses were -$35.20 million, 97.7% more than in 2022.
Financial StatementsNews
Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the developmen...
Pressure BioSciences Transcript: Status Update
Relocation to a new manufacturing facility has improved efficiency and reduced costs, despite causing filing delays. The company is launching a joint venture program, starting with Vita Forte, to accelerate commercialization of UltraShear-based products in nutraceuticals, skincare, and nootropics, with several product launches expected in the second half of 2024.
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
CANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and...
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
SOUTH EASTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investo...
Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”
PBIO Receives Critical Processor License for Industrial Hemp in MA . New License and Relocation to Enhanced Manufacturing Facility Allows Company to Supplement Production with West Coast Partner to Ma...
Pressure BioSciences Proxy statement: Proxy Filing
Pressure BioSciences filed a proxy statement on February 27, 2024, providing details for shareholder voting and corporate governance matters.
Pressure BioSciences reports Uncle Bud’s growth following acquisition
Pressure BioSciences announced early financial results from its January 19, 2024 acquisition of Uncle Bud’s Health & Wellness. Key highlights from Uncle Bud’s first month following its acquisition by ...
Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-ba...
Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
CANTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the developmen...
Pressure BioSciences Transcript: M&A Announcement
Pressure BioSciences Press release: M&A Announcement
Pressure BioSciences issued a press release on February 5, 2024, disclosing material business information to investors.
Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
Multi-Patented Nanoemulsification Platform Enables Wide-Range of Best-in-Class Health and Wellness Products - Revenue Impact of $5 Million in 2024 Anticipated with Further Acceleration in 2025 & Beyon...
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
SOUTH EASTON, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-ba...
Pressure Biosciences Acquires Uncle Bud’s Assets
Pressure Biosciences (PBIO) has released an update. The Company announced on January 22, 2024, that it has successfully completed the acquisition of Uncle Bud’s assets and has taken on certain…
Pressure Biosciences Acquires Uncle Bud’s Assets
Pressure Biosciences (PBIO) has released an update to notify the public and investors about an entry into a material definitive agreement. On January 9, 2024, Pressure BioSciences, Inc. acquired all…
Pressure BioSciences announces closing of Uncle Bud’s acquisition
Pressure BioSciences announced the closing of its acquisition of natural health and wellness leader Uncle Bud’s in an all-stock transaction. Incorporating UB’s 70+ already popular products, 865K membe...
Pressure BioSciences Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
SOUTH EASTON, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-ba...
Pressure BioSciences receives open order agreement for Nano-CBD Topical Spray
Pressure BioSciences announced the receipt of an Open Order Agreement for the purchase in 2024 of a minimum of 10,000 bottles of the Company’s Nano-CBD Topical Spray, with an initial…
Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
SOUTH EASTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-ba...
Pressure BioSciences announces filling order with partner for Uncle Bud’s
Pressure BioSciences announced on January 11, 2024 the execution of a definitive agreement to acquire renowned natural health and wellness leader Uncle Bud’s. Today, the Company announced the beginnin...
Pressure BioSciences' New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
Uncle Bud's, PBIO's New Consumer Products Business Unit, Kicks Off 2024 with a $252,000 Shipment of Sunburn Soother to One of the World's Largest Retailers Uncle Bud's, PBIO's New Consumer Products Bu...
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud's, Forward Integrating PBIO's UltraShear Platform into Multiple Markets
SOUTH EASTON, Mass.--(BUSINESS WIRE)--Pressure BioSciences (OTCQB: PBIO) Strategically Acquires Leading Health & Wellness Firm Uncle Bud's Hemp and CBD.
Pressure BioSciences evaluating AI, ML prospective partnerships
Pressure BioSciences announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships. The Company expects such collaborations to acce...
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies
Artificial Intelligence/Machine Learning Also Expected to Significantly Accelerate Advancements in PBIO's Patented, Innovative, and Enabling UltraShear Processing Platform SOUTH EASTON, MA / ACCESSWIR...
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform
Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced Nanomaterials SOUTH EASTON, M...